Financial results - ALIPHARM S.R.L.

Financial Summary - Alipharm S.r.l.
Unique identification code: 16024723
Registration number: J33/1199/2003
Nace: 4773
Sales - Ron
415.466
Net Profit - Ron
33.325
Employee
3
The most important financial indicators for the company Alipharm S.r.l. - Unique Identification Number 16024723: sales in 2023 was 415.466 euro, registering a net profit of 33.325 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Alipharm S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 207.920 259.938 284.342 331.260 344.973 321.038 438.351 386.975 392.286 415.466
Total Income - EUR 212.700 275.784 290.930 337.230 350.594 323.979 441.064 387.672 394.225 416.080
Total Expenses - EUR 192.720 256.686 267.395 298.760 309.505 291.778 386.516 344.356 356.829 379.085
Gross Profit/Loss - EUR 19.979 19.098 23.535 38.470 41.088 32.201 54.548 43.316 37.397 36.995
Net Profit/Loss - EUR 17.138 16.326 20.171 34.902 37.582 29.134 51.082 40.490 33.527 33.325
Employees 3 4 4 4 4 4 4 4 3 3
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales increased by 6.2%, from 392.286 euro in the year 2022, to 415.466 euro in 2023. The Net Profit decreased by -100 euro, from 33.527 euro in 2022, to 33.325 in the last year.

Check the financial reports for the company - Alipharm S.r.l.

Rating financiar

Financial Rating -
Alipharm S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Alipharm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Alipharm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Alipharm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Alipharm S.r.l. - CUI 16024723

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 12.489 11.444 5.157 4.850 4.412 2.096 5.269 3.460 31.344 25.470
Current Assets 244.098 256.712 245.843 256.826 260.552 261.465 280.116 277.935 124.086 146.307
Inventories 136.709 233.180 229.774 228.735 224.355 236.300 238.239 230.197 73.018 84.360
Receivables 10.195 11.364 7.339 22.653 26.037 23.682 35.707 36.761 49.518 45.144
Cash 97.194 12.168 8.730 5.437 10.161 1.482 6.170 10.977 1.549 16.804
Shareholders Funds 185.565 199.221 20.505 55.060 91.428 115.675 164.563 201.404 33.941 67.163
Social Capital 112 112 111 109 107 105 103 101 101 101
Debts 71.022 68.935 230.495 206.616 173.536 147.966 120.822 80.000 118.650 102.390
Income in Advance 0 0 0 0 0 0 0 0 2.839 2.224
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 146.307 euro in 2023 which includes Inventories of 84.360 euro, Receivables of 45.144 euro and cash availability of 16.804 euro.
The company's Equity was valued at 67.163 euro, while total Liabilities amounted to 102.390 euro. Equity increased by 33.325 euro, from 33.941 euro in 2022, to 67.163 in 2023. The Debt Ratio was 59.6% in the year 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Alipharm S.r.l.

Review
0.00
(0 reviews)
5 stars
(0)
4 stars
(0)
3 stars
(0)
2 stars
(0)
1 star
(0)

Comments - Alipharm S.r.l.

Similar services useful for checking companies and business development.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.